Fibrous dysplasia

Hormone Research

Volumn 57, Issue SUPPL. 2, 2002, Pages 79-82

  Schoenau, Eckhard ^a   Rauch, Frank ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bisphosphonates; Bone; Fibrous dysplasia; McCune Albright syndrome

Indexed keywords

BIOCHEMICAL MARKER; COLLAGEN FIBER; PAMIDRONIC ACID; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; BISPHOSPHONIC ACID DERIVATIVE; CYCLIC AMP; INTERLEUKIN DERIVATIVE;

ALPHA CHAIN; BONE TURNOVER; CELL SECRETION; CLINICAL FEATURE; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DRUG INDUCED DISEASE; DRUG MECHANISM; FIBROUS DYSPLASIA; HUMAN; MESENCHYME CELL; OSTEOCLAST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RADIOGRAPHY; SOMATIC MUTATION; ADOLESCENT; CHILD; CONNECTIVE TISSUE; FEMALE; GENETICS; MALE; METABOLISM; OSTEOBLAST; REVIEW;

ADOLESCENT; CHILD; CONNECTIVE TISSUE; CYCLIC AMP; DIPHOSPHONATES; FEMALE; FIBROUS DYSPLASIA OF BONE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; INTERLEUKINS; MALE; OSTEOBLASTS; OSTEOCLASTS;

EID: 0036279026     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058106     Document Type: Conference Paper

References (32)

1. Fibrous dysplasia of bone
2. Panostotic fibrous dysplasia: A congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphatasemia, and hypophosphatemia
3. Fibrous dysplasia of bone: The bone lesion unmasked
4. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunctions, with precocious puberty in females
5. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
6. The McCune-Albright syndrome: A lethal gene surviving by mosaicism
7. Identification of a mutation in the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome
8. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion
9. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome
10. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone
11. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia
12. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome
13. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia
14. Fibrous dysplasia of bone in the McCune-Albright syndrome: Abnormalities in bone formation
15. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: Site-specific patterns and recurrent histological hallmarks
16. The natural history of fibrous dysplasia
17. Hypophosphataemic osteomalacia in fibrous dysplasia
18. A case of McCune-Albright syndrome with hyperthyroidism and vitamin D-resistant rickets
19. Urinary cyclic adenosine 3′,5′-monophosphate response in McCune-Albright syndrome: Clinical evidence for altered renal adenylate cyclase activity
20. Malignancies in fibrous dysplasia
21. Fibrous dysplasia. An analysis of options for treatment
22. Polyostotic fibrous dysplasia. A long-term follow up of 8 patients
23. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia
24. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome)
25. A case of Albright's syndrome treated with calcitonin
26. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone
27. Effect of pamidronate on clinical symptoms and bone metabolism in fibrous dysplasia and McCune-Albright syndrome
28. Bisphosphonate therapy in fibrous dysplasia
29. Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome
30. Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome
31. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
32. Long-term aminobisphosphonate treatment of fibrous dysplasia: Spectacular increase in bone density